Genetic testing company 23andMe isn’t going away, despite declaring bankruptcy. The company and nearly all of its assets, ...

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.

The proposed sale is expected to close in the third quarter, subject to approval by the U.S. Bankruptcy Court for the Eastern ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Genetics and biotechnology company 23andMe today announced it will be acquired by Regeneron Pharmaceuticals for a purchase price of $256 million.

Regeneron Pharmaceutical (REGN) is buying 23andMe’s (MEHCQ) genetics business out of bankruptcy for $256 million, aiming to ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...